Growing pharma sector to boost laboratory, analysis and diagnostics market in India

Pharma/BioPharma |  News | 0 Comment | 17 Aug, 2017

The Indian pharma industry has been growing at a compounded annual growth rate (CAGR) of more than 15% over the last five years and is expected to grow to US$ 100 billion by 2025. The Unio...Read more

National Bio Entrepreneurship Competition launched by Y.S. Chowdary

Pharma/BioPharma |  News | 0 Comment | 17 Aug, 2017

The National Bio Entrepreneurship Competition which is a national platform to attract, identify and nurture bio-entrepreneurs with path-breaking ideas for societal impact has been launched ...Read more

UBM India announces 4rth edition of PharmaLytica event

Pharma/BioPharma |  News | 0 Comment | 04 Aug, 2017

UBM India, organizers of CPhI / P-MEC India, the leading global pharma trade show and conference, announced the 4th edition of PharmaLytica 2017. The two day event will be held at the HITEX...Read more

Cipla to explore marketing tie-up with Novartis

Pharma/BioPharma |  News | 0 Comment | 14 Jul, 2017

Cipla, India’s third largest drug maker, and Swiss giant Novartis are in early-stage discussions to jointly market asthma drug Xolair, just months after they ended a legal battle over...Read more

Takeda collaborates with Biological E

Pharma/BioPharma |  News | 0 Comment | 27 Jun, 2017

Japan’s Takeda and Biological E. Ltd. have agreed to collaborate on affordable combination vaccines. Takeda will transfer its measles and acellular pertussis vaccine bulk production ...Read more

Leo Pharma invests into Novopyxis

Pharma/BioPharma |  News | 0 Comment | 22 Jun, 2017

Leo Pharma announced an investment in the biotechnology company Novopyxis to support the development of an early-stage drug delivery device designed to increase the penetration of topical t...Read more

Glenmark starts a pact with APC Therapeutics

Pharma/BioPharma |  News | 0 Comment | 21 Jun, 2017

Domestic pharma major Glenmark Pharmaceuticals has entered into a licensing agreement with Boston-based APC Therapeutics Inc for development of a potential cancer treatment drug. Under the...Read more

AstraZeneca India receives marketing approval for Symbicort 320

Pharma/BioPharma |  News | 0 Comment | 20 Jun, 2017

AstraZeneca Pharma India Limited (AstraZeneca India), an international biopharmaceutical company has received marketing authorisation from the Drug Controller General of India (DCGI) for Sy...Read more

FDA approval to Zydus for migraine drug

Pharma/BioPharma |  News | 0 Comment | 20 Jun, 2017

Indian pharmaceutical major Zydus Cadila has managed to receive the final approval from the US health regulator Food and Drug Administration (USFDA) to market Eletriptan Hydrobromide tablet...Read more

Exclusive marketing rights to Pfizer in Europe

Pharma/BioPharma |  News | 0 Comment | 16 Jun, 2017

Pfizer and Basilea Pharmaceutica, an international biopharmaceutical company specializing in the research and development of anti-infective and oncological medicines, have entered into an a...Read more

USFDA nod for Aurobindo Pharma

Pharma/BioPharma |  News | 0 Comment | 15 Jun, 2017

Drug firm Aurobindo Pharma has received final approval from the US Food and Drug Administration (USFDA) to make oral suspension used for controlling serum phosphorus in patients with chroni...Read more

Lupin’s opoid drug gets USFDA nod

Pharma/BioPharma |  News | 0 Comment | 14 Jun, 2017

Drug firm Lupin has received final approval from the United States Food and Drug Administration (USFDA) to market its Oxycodone Hydrochloride tablets USP, in the strengths of 5 mg, 10 mg, 1...Read more

Pain relief gel launched by Ozone Pharmaceuticals

Pharma/BioPharma |  News | 0 Comment | 13 Jun, 2017

Aiming to tap the huge market opportunity in the growing segment of topical analgesic gels, Indian pharma major Ozone Pharmaceuticals Ltd has launched DFO 4X Gel, an advanced topical analge...Read more

Generic Azilect tablets launched by Mylan

Pharma/BioPharma |  News | 0 Comment | 05 Jun, 2017

Mylan announced the U.S. launch of Rasagiline Tablets, 0.5 mg and 1 mg, a generic version of the reference listed drug, Teva's Azilect Tablets. Mylan received final approval from the U.S. F...Read more

Clinical trials for Bharat Biotech’s Chikungunya vaccine

Pharma/BioPharma |  News | 0 Comment | 05 Jun, 2017

Phase 1 human clinical trials of the indigenously developed Chikungunya (CHIKV) vaccine by Bharat Biotech is underway in India to evaluate the vaccine’s safety, tolerability and immun...Read more

Pfizer India to acquire AstraZeneca’s Neksium for Rs 750mn

Pharma/BioPharma |  News | 0 Comment | 31 May, 2017

Pfizer Limited (India) informed the stock exchange that it has entered into an agreement with AstraZeneca AB, Sweden, to acquire the brand “Neksium” in India for a value of INR ...Read more

Sun Pharma reports 9% growth in FY2017 at Rs. 30,264 crores

Pharma/BioPharma |  News | 0 Comment | 30 May, 2017

Sun Pharmaceutical Industries Ltd, India's top pharmaceutical company, reported a growth of 9% in sales / income from operations at Rs. 30,264 crores, over same period last year. The compa...Read more

Sun Pharma reports 8% drop in Q4 gross sales at Rs. 6,825 crores

Pharma/BioPharma |  News | 0 Comment | 30 May, 2017

Sun Pharmaceutical Industries Ltd, the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company reported de-growth of 8% in sales/ income Incom...Read more